Abstract

ObjectiveThe aim of our study was to compare the reference intervals (RIs) [median (2.5th-97.5th percentiles)] for thyroid-stimulating hormone (TSH) between subgroups stratified by ethnicity and iodine status in a global context.Design and MethodsPrimary data were derived from a recently published cross-sectional study in mainland China. Secondary data were obtained from online databases. The RIs for TSH were calculated in the reference population according to the National Academy of Clinical Biochemistry (NACB) standard and in the disease-free population. A meta-analysis of ethnicity- and iodine status-specific TSH RIs was performed.ResultsThe primary data showed that the TSH RI (mU/L) in the disease-free population was 2.33 (0.67, 7.87), which is wider than the published RI [2.28 (0.74, 7.04)] in the reference population. The meta-analysis showed that whether in the reference or disease-free population, the RIs in Yellows were much higher than those in Caucasians. In the reference population, the median and 2.5th percentile in the iodine-sufficient subgroup were both lower than the iodine-deficient or more-than-adequate subgroup, while the 97.5th percentile showed a positive trend with increasing sufficiency of iodine. However, in the disease-free population, the iodine-sufficient subgroup had a lower median and 97.5th percentile but higher 2.5th percentile than the iodine-deficient subgroup.ConclusionYellows have a higher TSH RI than Caucasians. In the reference population, both the median and 2.5th percentile TSH in the iodine-sufficient population were the lowest among the different iodine status subgroups, while the 97.5th percentile of TSH showed an upward trend with increasing iodine sufficiency.

Highlights

  • Subclinical hypothyroidism (SCH) is characterized by elevated serum thyroid-stimulating hormone (TSH) and normal thyroxine levels and is the most common form of thyroid dysfunction [1]

  • SCH with TSH levels higher than 10 mU/L, especially when coupled with positivity for thyroid peroxidase antibody (TPOAb), is likely to progress to overt hypothyroidism [7]

  • A previous study confirmed that the upper limit of the TSH reference interval (RI) (7.04 mU/L) was a record high in mainland China based on the National Academy of Clinical Biochemistry (NACB) standard

Read more

Summary

Introduction

Subclinical hypothyroidism (SCH) is characterized by elevated serum thyroid-stimulating hormone (TSH) and normal thyroxine levels and is the most common form of thyroid dysfunction [1]. The latest cross-sectional study in mainland China showed that the prevalence of SCH is 12.93% [3]. Many studies have shown that SCH is closely related to the occurrence and progression of hypertension, dyslipidemia, coronary heart disease and other diseases [5] and is even related to the risk of cardiovascular and all-cause mortality [6]. SCH with TSH levels higher than 10 mU/L, especially when coupled with positivity for thyroid peroxidase antibody (TPOAb), is likely to progress to overt hypothyroidism [7]. SCH has increasingly become a focus of research in the field of endocrinology

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.